Key result
AF is linked to lower post-contrast ventricular T1 times, indicating diffuse LV fibrosis.
Why the study?
Diffuse myocardial fibrosis is a hallmark of cardiomyopathy not visualized on delayed-enhancement CMR, and whether it is present in AF or reflects cardiomyopathy was unclear.
Is atrial fibrillation associated with increased diffuse left ventricular myocardial fibrosis as measured by CMR T1 mapping?
Cross-Sectional (n=90)
Is atrial fibrillation associated with increased diffuse left ventricular myocardial fibrosis as measured by CMR T1 mapping?
CMR T1 mapping demonstrates that patients with atrial fibrillation have increased diffuse left ventricular fibrosis, which correlates with AF burden and adverse ventricular remodeling.
Answers are grounded in this paper and cite their sources.
AF associated with greater ventricular fibrosis on T1 mapping; hypothesis-generating for causality, should not yet change practice.
OBJECTIVES: The purpose of this study was to evaluate diffuse myocardial fibrosis of the left ventricle (LV) in patients with atrial fibrillation (AF). BACKGROUND: Diffuse myocardial fibrosis is a hallmark of cardiomyopathy. Unlike replacement fibrosis, it is not visualized on delayed-enhancement cardiac magnetic resonance (CMR) imaging, but may be quantified with contrast-enhanced T(1) mapping methods. In atrial fibrillation (AF), it may be induced by arrhythmia or reflect pre-existing cardiomyopathy. METHODS: Ninety subjects underwent CMR using a clinical 1.5-T scanner: 23 controls, 40 paroxysmal AF patients, and 27 persistent AF patients. Cardiac morphology and function was evaluated from CMR cine imaging. A histologically validated T(1) mapping sequence was used to calculate post-contrast T(1) relaxation time (T(1) time) of the LV myocardium as an index of diffuse myocardial fibrosis. RESULTS: Age was similar across controls, paroxysmal AF patients, and persistent AF patients (54 ± 12 years, 58 ± 9 years, and 56 ± 10 years, p = NS). Persistent AF patients had larger indexed left atrium volume (55 ± 18 ml vs. 41 ± 12 ml and 47 ± 14 ml) and lower ejection fraction (54 ± 10% vs. 65 ± 6% and 61 ± 8%) than controls and paroxysmal AF patients (p < 0.05). Post-contrast ventricular T(1) time differed across all groups (controls, 535 ± 86 ms; paroxysmal AF, 427 ± 95 ms; persistent AF, 360 ± 84 ms; p < 0.001). Univariate predictors of post-contrast ventricular T(1) time included age, sex, AF category, ejection fraction, LV mass, congestive heart failure, and body mass index. After multivariate analysis, age, AF category, and ejection fraction remained independent predictors. CONCLUSIONS: Post-contrast ventricular T(1) mapping identifies diffuse LV fibrosis in patients with AF and provides new insights into the association between AF and adverse ventricular remodeling.
No takes yet. Share an insight, caveat, or question.
Ling et al. (2012) conducted a cross-sectional in Atrial fibrillation (n=90). Atrial fibrillation vs. Controls was evaluated on Post-contrast ventricular T(1) time (p=<0.001). Atrial fibrillation was associated with lower post-contrast ventricular T1 times (paroxysmal 427 ms, persistent 360 ms) vs controls, indicating diffuse left ventricular fibrosis.
Synapse has enriched 10 related papers. Consider them for comparative context: